Crossmark

Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats

Crossref DOI link: https://doi.org/10.1186/s12906-018-2119-7

Published Online: 2018-02-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chi, Cheng

Liu, Xiao-ya

Hou, Fei

Yu, Xiao-zheng

Li, Chun-yun

Cui, Li-jian

Liu, Rui-xia

Yin, Cheng-hong http://orcid.org/0000-0001-6532-0783
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81300334, 81341090)

WBE Liver Fibrosis Foundation (CFHPC20120145)
More Information

Article History

Received: 28 April 2017

Accepted: 29 January 2018

First Online: 5 February 2018

Ethics approval

: Animal care and experimental procedures were approved by the Ethics Committee of Beijing Friendship Hospital, Capital Medical University (Beijing, China).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.